Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 134Precursor Cell Lymphoblastic Leukemia-Lymphoma 116Myelodysplastic Syndromes 112Leukemia, Lymphocytic, Chronic, B-Cell 102Lymphoma, Non-Hodgkin 98Hodgkin Disease 95Leukemia 86Multiple Myeloma 85Lymphoma 72Lymphoma, Mantle-Cell 67Lymphoma, Follicular 67Lymphoma, Large B-Cell, Diffuse 64Leukemia, Myelogenous, Chronic, BCR-ABL Positive 60Myeloproliferative Disorders 58Lymphoma, B-Cell, Marginal Zone 58Burkitt Lymphoma 53Leukemia, Myelomonocytic, Chronic 51Congenital Abnormalities 51Leukemia, Myeloid, Chronic-Phase 49Lymphoma, Large-Cell, Immunoblastic 46Leukemia, Myeloid, Accelerated Phase 43Hematologic Neoplasms 42Anemia, Refractory, with Excess of Blasts 40Graft vs Host Disease 39Primary Myelofibrosis 36Waldenstrom Macroglobulinemia 34Neoplasms, Plasma Cell 33Blast Crisis 33Recurrence 30Lymphoma, T-Cell, Cutaneous 30

Interventions

Temozolomide 1TIC10 compound 1Radiotherapy, Intensity-Modulated 1Mycophenolic Acid 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Glioblastoma × Mycophenolic Acid × Clear all
NCT07605364 2026-05-26

Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer

Alliance for Clinical Trials in Oncology

Phase 2/3 Not yet recruiting
422 enrolled
CNS

Advanced Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡